Top 10 Reasons to include CO210-500 Series as Part of a Cancer Support/Treatment Protocol

1. Can help support pain control when conventional options are not enough, especially in palliative care settings.

2. Can help reduce chemotherapy-related nausea and vomiting, one of the better-supported cannabinoid uses in cancer care.

3. Can support appetite in patients struggling with weight loss, food aversion, or reduced intake.

4. Full-spectrum formulation may provide a broader cannabinoid and terpene profile than isolated THC or CBD products.

5. High-potency format may be useful when lower-strength cannabis oils do not provide adequate symptom relief.

6. Non-smoking option, avoiding the respiratory risks associated with smoked cannabis.

7. Can assist sleep quality, especially when pain, anxiety, or treatment discomfort disrupt rest.

8. Can support emotional comfort, including distress, anxiety, and end-of-life discomfort, though evidence is more mixed than for nausea and pain.

9. Flexible dosing potential, allowing gradual titration under guidance instead of a one-size-fits-all approach.

10. Can be integrated as supportive care, not as a replacement for oncology treatment, chemotherapy, radiation, immunotherapy, surgery, or physician-directed palliative care.

Important: cannabis products do not cure cancer, and should be used only with medical oversight, especially with high-THC products, other medications, heart conditions, psychiatric history, pregnancy, or breastfeeding.